NCT00327223View on ClinicalTrials.gov

Safety Study of Imexon Treatment of Patients With Metastatic or Disseminated Malignancy

PHASE1CompletedINTERVENTIONAL
Enrollment

18

Participants

Timeline

Start Date

November 30, 2005

Primary Completion Date

September 30, 2006

Study Completion Date

October 31, 2006

Conditions
Neoplasm Metastasis
Interventions
DRUG

imexon

Trial Locations (4)

12208

US Oncology Albany, New York Oncology, Albany

46227

US Oncology Indiana, Indianapolis

75702

US Oncology, Tyler Cancer Center, Tyler

76508

Investigational Site 014, Temple

Sponsors
All Listed Sponsors
lead

AmpliMed Corporation

INDUSTRY